DOC Analyst Ratings
Moderate Buy
4 Buy
10 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
DOC Stock 12 Month Forecast
Average Price Target
―| Highest Price Target$422.49 | Average Price Target$388.09 | Lowest Price Target$354.89 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Wells Fargo
$371.79
Hold
―
Reiterated
09/01/26
Barclays
$388.69→$405.59
Hold
―
Reiterated
08/31/26
Bank of America Securities
$405.59→$422.49
Buy
―
Reiterated
08/24/26
UBS
$363.34
Hold
―
Assigned
08/21/26
J.P. Morgan
$371.79
Hold
―
Reiterated
08/18/26
Evercore ISI
$388.69
Hold
―
Reiterated
08/12/26
Citi
$337.99→$371.79
Hold
―
Reiterated
08/11/26
RBC Capital
$354.89→$405.59
Buy
―
Reiterated
08/10/26
Cantor Fitzgerald
$337.99→$388.69
Hold
―
Reiterated
08/05/26
Morgan Stanley
$371.79
Hold
―
Reiterated
08/05/26
Scotiabank
$354.89
Hold
―
Reiterated
08/05/26
Mizuho Securities
$354.89→$405.59
Buy
―
Reiterated
07/06/26
Raymond James
$405.59
Hold
―
Initiated
06/16/26
BMO Capital
$337.99→$405.59
Buy
―
Reiterated
06/15/26
Robert W. Baird
$321.09→$354.89
Buy
―
Reiterated
05/13/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wells Fargo
$371.79
Hold
―
Reiterated
09/01/26
Barclays
$388.69→$405.59
Hold
―
Reiterated
08/31/26
Bank of America Securities
$405.59→$422.49
Buy
―
Reiterated
08/24/26
UBS
$363.34
Hold
―
Assigned
08/21/26
J.P. Morgan
$371.79
Hold
―
Reiterated
08/18/26
Evercore ISI
$388.69
Hold
―
Reiterated
08/12/26
Citi
$337.99→$371.79
Hold
―
Reiterated
08/11/26
RBC Capital
$354.89→$405.59
Buy
―
Reiterated
08/10/26
Cantor Fitzgerald
$337.99→$388.69
Hold
―
Reiterated
08/05/26
Morgan Stanley
$371.79
Hold
―
Reiterated
08/05/26
Scotiabank
$354.89
Hold
―
Reiterated
08/05/26
Mizuho Securities
$354.89→$405.59
Buy
―
Reiterated
07/06/26
Raymond James
$405.59
Hold
―
Initiated
06/16/26
BMO Capital
$337.99→$405.59
Buy
―
Reiterated
06/15/26
Robert W. Baird
$321.09→$354.89
Buy
―
Reiterated
05/13/26
Best Analysts Covering Healthpeak Properties
3 Months
Success Rate
16/28 ratings generated profit
Average Return
+1.34%
Copying Juan C. Sanabria's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +1.34% per trade.
1 Year
Success Rate
13/28 ratings generated profit
Average Return
+5.55%
Copying Michael Carroll's trades and holding each position for 1 Year would result in 46.43% of your transactions generating a profit, with an average return of +5.55% per trade.
2 Years
Success Rate
12/15 ratings generated profit
Average Return
+8.33%
Copying Vikram Malhotra's trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +8.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
DOC Analyst Recommendation Trends
Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
10
11
8
4
3
Hold
9
12
14
18
16
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
23
22
22
19
Each month's total comprises the sum of three months' worth of ratings.
DOC Financial Forecast
DOC Stock Forecast FAQ
What is MX:DOC’s average 12-month price target, according to analysts?
Based on analyst ratings, Healthpeak Properties’s 12-month average price target is 388.09.
What is MX:DOC’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MX:DOC, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Healthpeak Properties a Buy, Sell or Hold?
Healthpeak Properties has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 10 hold ratings and 0 sell ratings.
What is Healthpeak Properties’s share price target?
The average share price target for Healthpeak Properties is 388.09. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $422.49 ,and the lowest forecast is $354.89. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is $422.49 ,and the lowest forecast is $354.89. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about Healthpeak Properties?
Healthpeak Properties’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of Healthpeak Properties?
To buy shares of MX:DOC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.